Michael W. Major studied Pharmacy at the Medical Academy in Lodz, Poland. Finished his academic carrier as a tenured Professor of Medicinal Chemist at age of 33. During his time at academia he published 40+ peer review publications and was an exchange scientist at Northwestern and McMaster University and Alexander von Humboldt scholar at University of Stuttgart.His career in Milwaukee, WI started with Aldrich Chemical, followed by Cambridge Chemical. In 1998 he started Major Laboratories and in 1999 Cambridge Major Laboratories. In 2003, built his first 60 000 Sq. Ft. R&D and small scale API manufacturing facility in Germantown, WI, follow by a second large scale API manufacturing site in 2008. Both facilities were operational one year from the start of construction.Founder and co-founder of few virtual companies focused on bringing to the market branded drugs and niche injectable generics. One of them, Namigen LLC formed in partnership with Nathan Barishansky, filed four ANDA submission. In December 2016 their first product, Sodium Nitroprusside Injection, got FDA approval.Michael believes in science based manufacturing and organic growth. In summer 2016 Michael started construction of MPP Group facilities. In December 2017, the company has celebrated the first anniversary of being in business and has experience a substantial growth. That required separation of the two principal activities; development of injectable Drug Product from Wound Care and Nutraceutical Products. Both subdivision are also offering services particular to their profile. Please check our new web site www.mppgroupllc.com to get more details.In his words there are three components to success: hard work, knowledge and some luck. Michael believes no one can succeed without integrity, honesty, common sense and leadership skills.Michael enjoys the company of others, wine, travel, history and fine arts. He speaks five languages: Polish, German, English, Italian and French (still needs improvement).